From Cancer Scare to Comeback, Abivax Shares Erase a Month of Losses in a Day
Abivax stock jumped 38% after new obefazimod trial data eased the cancer-safety fears that had erased weeks of gains.
Opent in een nieuw tabblad. Via Cryptopage meten we de klik voor statistieken.
Partner